![Research priorities towards precision antibiotic therapy to improve patient care - The Lancet Microbe Research priorities towards precision antibiotic therapy to improve patient care - The Lancet Microbe](https://www.thelancet.com/cms/attachment/f3a8c0a4-6ebd-4f46-96ad-27e8228a9bf1/gr1_lrg.jpg)
Research priorities towards precision antibiotic therapy to improve patient care - The Lancet Microbe
![Second-line levofloxacin-based quadruple therapy versus bismuth-based quadruple therapy for Helicobacter pylori eradication and long-term changes to the gut microbiota and antibiotic resistome: a multicentre, open-label, randomised controlled trial ... Second-line levofloxacin-based quadruple therapy versus bismuth-based quadruple therapy for Helicobacter pylori eradication and long-term changes to the gut microbiota and antibiotic resistome: a multicentre, open-label, randomised controlled trial ...](https://www.thelancet.com/cms/attachment/746449a9-d6d5-4dd3-bd7d-4e15e35a1bad/gr1_lrg.jpg)
Second-line levofloxacin-based quadruple therapy versus bismuth-based quadruple therapy for Helicobacter pylori eradication and long-term changes to the gut microbiota and antibiotic resistome: a multicentre, open-label, randomised controlled trial ...
![Predictors of triple therapy treatment failure among H. pylori infected patients attending at a tertiary hospital in Northwest Tanzania: a prospective study | BMC Infectious Diseases | Full Text Predictors of triple therapy treatment failure among H. pylori infected patients attending at a tertiary hospital in Northwest Tanzania: a prospective study | BMC Infectious Diseases | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12879-019-4085-1/MediaObjects/12879_2019_4085_Fig1_HTML.png)
Predictors of triple therapy treatment failure among H. pylori infected patients attending at a tertiary hospital in Northwest Tanzania: a prospective study | BMC Infectious Diseases | Full Text
![Antibiotics | Free Full-Text | Empiric “Three-in-One” Bismuth Quadruple Therapy for Second-Line Helicobacter pylori Eradication: An Intervention Study in Southern Italy Antibiotics | Free Full-Text | Empiric “Three-in-One” Bismuth Quadruple Therapy for Second-Line Helicobacter pylori Eradication: An Intervention Study in Southern Italy](https://www.mdpi.com/antibiotics/antibiotics-11-00078/article_deploy/html/images/antibiotics-11-00078-g001.png)
Antibiotics | Free Full-Text | Empiric “Three-in-One” Bismuth Quadruple Therapy for Second-Line Helicobacter pylori Eradication: An Intervention Study in Southern Italy
![Comparison between daily single-dose triple therapy and conventional triple therapy on patient compliance and Helicobacter pylori eradication: A randomized controlled trial | SpringerLink Comparison between daily single-dose triple therapy and conventional triple therapy on patient compliance and Helicobacter pylori eradication: A randomized controlled trial | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12664-018-0916-z/MediaObjects/12664_2018_916_Figa_HTML.png)
Comparison between daily single-dose triple therapy and conventional triple therapy on patient compliance and Helicobacter pylori eradication: A randomized controlled trial | SpringerLink
![Microorganisms | Free Full-Text | Factors Affecting the Intraluminal Therapy for Helicobacter pylori Infection Microorganisms | Free Full-Text | Factors Affecting the Intraluminal Therapy for Helicobacter pylori Infection](https://www.mdpi.com/microorganisms/microorganisms-10-00415/article_deploy/html/images/microorganisms-10-00415-g001.png)
Microorganisms | Free Full-Text | Factors Affecting the Intraluminal Therapy for Helicobacter pylori Infection
![Managing antibiotics wisely in a neonatal intensive care unit in a low resource setting | Journal of Perinatology Managing antibiotics wisely in a neonatal intensive care unit in a low resource setting | Journal of Perinatology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41372-022-01388-4/MediaObjects/41372_2022_1388_Fig1_HTML.png)